Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fc06cad2b58bbfcc30e3c96a6eb6c926 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 |
filingDate |
2010-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2013-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa9dc6d8177c30734082bba279e2f3db http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9dfb4db4466b9f77c5e550b3c6ffe2e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68d0ffd678642d86867f4711e83b68ec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a43ec256e872aa04fbfc1c8158d5dd9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53021e2574a13a0bcd9a122e31efb4f9 |
publicationDate |
2013-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
TW-I412369-B |
titleOfInvention |
Pharmaceutical composition for inhibiting inflammatory reaction of cancer cells |
abstract |
The present invention provides a pharmaceutical composition for inhibiting cancer cell inflammation. Said composition is store-operated channel (SOC) inhibitors. The inhibitors mentioned herein comprise siRNA and chemical antagonist. By blocking the calcium influx of cancer cells, the inhibitors are useful for slowing cancer cell inflammation. |
priorityDate |
2010-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |